BRAF mutation and neoadjuvant chemo-immunotherapy, is it worthwhile? - Gallina FT; Cecere FL; Bergomi S; Buglioni S; Visca P; Landi L; Cappuzzo F (Lung cancer (Amsterdam, Netherlands), 2025)